EP2968294
7-bensýl-10-(2-metýlbensýl)-2,6,7,8,9,10-hexahýdróimídasó[1,2-A]pýridó[4,3-D]pýrimidín-5(3H)-ón til notkunar við meðferð á krabbameini
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
13.3.2014EP published:
1.5.2019EP application number:
14775569.8
EP translation filed:
12.7.2019Grant published:
15.8.2019EPO information:
European Patent Register
Max expiry date:
12.3.2034Expiry date:
12.3.2027Next due date:
31.3.2027
Title:
7-BENZYL-10-(2-METHYLBENZYL)-2,6,7,8,9,10-HEXAHYDROIMIDAZO[1,2-A]PYRIDO[4,3-D]PYRIMIDIN-5(3H)-ON FOR USE IN THE TREATMENT OF CANCER
Timeline
Today
13.3.2014EP application
1.5.2019EP Publication
12.7.2019Translation submitted
15.8.2019Registration published
12.3.2027Expires
Owner
Name:
Oncoceutics, Inc.Address:
3675 Market Street Suite 200, 19104, Philadelphia, PA, US
Inventor
Name:
STOGNIEW, MartinAddress:
Blue Bell, PA, US
Name:
ALLEN, Joshua, E.Address:
Cambridge, MA, US
Name:
NALLAGANCHU, Bhaskara, RaoAddress:
Hillsborough, NJ, US
Name:
POTTORF, Richard, S.Address:
Indianapolis, IN, US
Name:
OLSON, Gary, L.Address:
Monmouth Junction, NJ, US
Agent
Name:
Novagraaf BrevetsAddress:
Bâtiment O2, 2 rue Sarah Bernhardt CS90017, FR
Priority
Number:
201361779828 PDate:
13.3.2013Country:
US
Number:
201361904718 PDate:
15.11.2013Country:
US
Classification
Categories:
A61K 31/519, A61K 31/44, C07D 471/14, A61K 45/06, A61P 35/00
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 18.2.2020
Expires: 12.3.2021
Payer: Árnason Faktor ehf.
Number: 8
Paid: 8.2.2021
Expires: 12.3.2022
Payer: Árnason Faktor ehf.
Number: 9
Paid: 18.2.2022
Expires: 12.3.2023
Payer: Patice ehf.
Number: 10
Paid: 20.2.2023
Expires: 12.3.2024
Payer: Árnason Faktor ehf.
Number: 11
Paid: 28.2.2024
Expires: 12.3.2025
Payer: Árnason Faktor ehf.
Number: 12
Paid: 11.2.2025
Expires: 12.3.2026
Payer: Árnason Faktor ehf.
Number: 13
Paid: 12.3.2026
Expires: 12.3.2027
Payer: Árnason Faktor ehf.